TCL Archive Science Policy: Increased Cancer Death Rate For Atomic Vets Not Significant, OIM Says October 29, 1999
TCL Archive Phase III Trebananib Trial Fails OS Endpoint In Recurrent Platinum-Resistant Ovarian Cancer November 28, 2014